latest news releases from the newsroom
Renasant Corporation Announces Increase in Third Quarter Earnings
TUPELO, Miss., Oct. 17, 2006 (PRIMEZONE) -- Renasant Corporation (Nasdaq:RNST) (the "Company") today announced results for the third quarter of 2006. Basic earnings per share for the third quarter of 2006 were $.43, up 5%, and diluted earnings per share were $.42, up 5%, compared to basic earnings per share of $.41 and diluted earnings per share of $.40, respectively, for the third quarter of 2005. Net income for the third quarter of 2006 was $6,632,000, up 5%, or $307,000, from the third quarter of 2005. Prior period per share amounts have been restated for the 3 for 2 stock split issued during the third quarter of 2006.
Lincoln Bancorp Announces Third Quarter Earnings
PLAINFIELD, Ind., Oct. 17, 2006 (PRIMEZONE) -- Lincoln Bancorp (Nasdaq:LNCB) (the "Company"), the holding company of Lincoln Bank (the "Bank"), announced today that net income for the third quarter ended September 30, 2006 was $840,000 or $.17 basic earnings per share and $.16 diluted earnings per share. This compared to net income of $1,215,000 for the third quarter of 2005 or $.24 for both basic and diluted income per share.
NowAuto Group, Inc.
NowAuto Group, Inc. Announces Fiscal Year End Results
TEMPE, Ariz., Oct. 17, 2006 (PRIMEZONE) -- NowAuto Group, Inc. (OTCBB:NAUG) today announced results of its fiscal 2006 year. The Company reported revenue of $11.68 million, up from $2.09 million in the prior year, and Net Income before impairment of $0.02 per diluted share versus a net Loss of $0.15 per diluted share in the prior year.
Independent Results Support the Use of BioCurex Technology for Gastric Cancer
RICHMOND, British Columbia, Oct. 17, 2006 (PRIMEZONE) -- BioCurex Inc. (OTCBB:BOCX) announced today that a group of scientists led by Dr. So Tsuboi from the Shigei Medical Research Hospital, Japan, have published results on the expression of the receptor for AFP (RECAF) in normal, benign and malignant stomach tissue. The tissue study used a variation of the Company's Histo-RECAF kit. The results indicate that RECAF was expressed in 34 out of 47 cancers and not expressed in 59 out of 61 normal or benign tissues. The authors conclude that RECAF may become a new clinically useful marker of gastric cancer.
IElement Corporation Enters Into Letter of Intent With US Wireless Online
DALLAS, Oct. 17, 2006 (PRIMEZONE) -- IElement Corporation (OTCBB:IELM) (Frankfurt:SZQ1.F) (Frankfurt:IELM.F), a nationwide provider of advanced communication services and Voice over Internet Protocol (VoIP) solutions, announced today that it has entered into a non-binding letter of intent to purchase a controlling interest in US Wireless Online, Inc. (Pink Sheets:UWRL), one of the nation's largest wireless internet service providers.
Izard Nobel LLP
Schatz & Nobel, P.C. Announces Class Action Lawsuit Against Legg Mason, Inc. -- LM
HARTFORD, Conn., Oct. 17, 2006 (PRIMEZONE) -- The law firm of Schatz & Nobel, P.C., which has significant experience representing investors in prosecuting claims of securities fraud, announces that a lawsuit seeking class action status has been filed in the United States District Court for the Southern District of New York on behalf of all persons who purchased the common stock of Legg Mason, Inc. ("Legg Mason" or the "Company") (NYSE:LM) between June 24, 2005 and July 24, 2006, inclusive, (the "Class Period"). Also included are those who acquired shares in a secondary offering on 3/9/06 or through the acquisitions of Permal or Worldwide Asset Management